Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arrowhead Pharmaceuticals, Inc. - Common Stock
(NQ:
ARWR
)
15.07
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Arrowhead Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases
March 10, 2025
Arrowhead's ARO-C3 cut C3 levels by up to 89% and proteinuria by 41% in a Phase 1/2 trial. Additional results will be presented at a 2025 medical meeting.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 14, 2025
Via
Benzinga
Earnings Scheduled For February 10, 2025
February 10, 2025
Via
Benzinga
A Look Ahead: Arrowhead Pharma's Earnings Forecast
November 25, 2024
Via
Benzinga
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
January 09, 2025
Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Government
Exposures
Artificial Intelligence
Political
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
December 01, 2024
8 mid-cap stocks saw impressive gains last week. Archer, Scholar Rock, Arrowhead, Iris Energy, Hims & Hers, SoundHound, Joby Aviation, and Urban Outfitters all performed well.
Via
Benzinga
Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
December 01, 2024
Top performers last week: RIVN, RKLB, SRPT, EXAS, ESTC, ULTA, MRNA, RL, CPRT, SNAP. Any in your portfolio? Citigroup raises price target on ULTA and SNAP.
Via
Benzinga
Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday
November 27, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 26, 2024
Via
Benzinga
Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On?
November 26, 2024
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) shares are trading higher Tuesday after the company announced a global licensing and collaboration agreement with Sarepta Therapeutics Inc. (NASDAQ: SRPT)....
Via
Benzinga
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
November 26, 2024
Via
Benzinga
Arrowhead Launches 25% On A Massive Licensing Deal With Sarepta
November 26, 2024
The deal focuses on four clinical-stage drugs, three preclinical assets and a potential five new targets.
Via
Investor's Business Daily
Earnings Scheduled For November 26, 2024
November 26, 2024
Via
Benzinga
Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
October 18, 2024
The company is working on treatments for forms of muscular dystrophy, and is taking on some of the biggest names in pharma.
Via
Investor's Business Daily
ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q3 2024
August 08, 2024
ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the third quarter of 2024.
Via
InvestorPlace
S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday
July 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
July 05, 2024
A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.
Via
Investor's Business Daily
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
June 28, 2024
Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025.
Via
InvestorPlace
Why Arrowhead Pharmaceuticals (ARWR) Stock Is Seeing Blue Skies
June 24, 2024
Arrowhead Pharmaceuticals shares are trading higher by more than 6% during Monday's session. The company announced that it presented preclinical data on ARO-INHBE.
Via
Benzinga
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
June 24, 2024
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.
Via
Benzinga
Why Is Arrowhead Pharmaceuticals Stock Trading Higher On Monday?
June 03, 2024
Arrowhead Pharmaceuticals announced Phase 3 PALISADE study results showing significant triglyceride reduction in familial chylomicronemia syndrome patients treated with plozasiran.
Via
Benzinga
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
Via
Benzinga
Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
May 14, 2024
These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet.
Via
InvestorPlace
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q2 2024
May 09, 2024
ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment
May 02, 2024
Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company said EPS decreased by 1% due to higher operating and interest expenses...
Via
Benzinga
The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024
April 05, 2024
With risk-on sentiment in place, investors may be looking for the most undervalued Russell 2000 stocks to buy in April.
Via
InvestorPlace
NetApp, Zoom Video And 2 Other Stocks Insiders Are Selling
April 04, 2024
The Nasdaq 100 closed higher by around 0.2% on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Via
InvestorPlace
The 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024
March 11, 2024
The Russell 2000 is up about 4% year to date, and could push higher, taking the most undervalued Russell 2000 stocks along for the ride.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.